The FDA involves Rybelsus to hold a black box warning—essentially the most serious variety of warning—about the chance of thyroid C-mobile tumors. This warning stems from animal research exhibiting that semaglutide and related drugs caused thyroid tumors, together with most cancers, in rodents.